A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2017

Conditions
Acute Ischemic Stroke From Large Vessel Occlusion
Interventions
DEVICE

Penumbra System with Separator 3D

The Separator 3D is an additional Separator with a new tip configuration for the Penumbra System.

DEVICE

Penumbra System alone

The Penumbra System® is a new generation of neuro-embolectomy devices specifically designed to remove thrombus through aspiration.The treatment paradigm of this System involves the introduction of the Reperfusion Catheter through a guide catheter into the intracranial vasculature, and guided over an appropriate guidewire to the site of primary occlusion. The Reperfusion Catheter is used in parallel with the Separator and an aspiration source (Aspiration Pump) to separate the thrombus and aspirate it from the occluded vessel.

Trial Locations (8)

6106

Hartford Hospital, Hartford

14209

Kaleida Health, Buffalo

30303

Grady Health System, Atlanta

37232

Vanderbilt University Medical Center, Nashville

55102

St. Joseph Hospital- Healtheast, Saint Paul

80112

Swedish Medical Center, Denver

92658

Hoag Hospital, Newport Beach

11794-8122

Stony Brook University Hospital, Stony Brook

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Penumbra Inc.

INDUSTRY

NCT01584609 - A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter